| Bone marrow angiogenesis and progression in multiple myeloma A Vacca, D Ribatti, L Roncali, G Ranieri, G Serio, F Silvestris, ... British journal of haematology 87 (3), 503-508, 1994 | 837 | 1994 |
| Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma A Vacca, D Ribatti, M Presta, M Minischetti, M Iurlaro, R Ria, A Albini, ... Blood, The Journal of the American Society of Hematology 93 (9), 3064-3073, 1999 | 811 | 1999 |
| Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo D Ribatti, M Presta, A Vacca, R Ria, R Giuliani, P Dell’Era, B Nico, ... Blood, The Journal of the American Society of Hematology 93 (8), 2627-2636, 1999 | 722 | 1999 |
| Epithelial-mesenchymal transition in cancer: a historical overview D Ribatti, R Tamma, T Annese Translational oncology 13 (6), 100773, 2020 | 609 | 2020 |
| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 552 | 2018 |
| The role of pericytes in angiogenesis D Ribatti, B Nico, E Crivellato The International journal of developmental biology 55 (3), 261-268, 2011 | 516 | 2011 |
| Broad targeting of angiogenesis for cancer prevention and therapy Z Wang, C Dabrosin, X Yin, MM Fuster, A Arreola, WK Rathmell, ... Seminars in cancer biology 35, S224-S243, 2015 | 513 | 2015 |
| Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic G Ranieri, R Patruno, E Ruggieri, S Montemurro, P Valerio, D Ribatti Current medicinal chemistry 13 (16), 1845-1857, 2006 | 423 | 2006 |
| Acknowledging the use of human cadaveric tissues in research papers: Recommendations from anatomical journal editors J Iwanaga, V Singh, A Ohtsuka, Y Hwang, HJ Kim, J Moryś, KS Ravi, ... Clinical Anatomy 34 (1), 2-4, 2021 | 411 | 2021 |
| “Sprouting angiogenesis”, a reappraisal D Ribatti, E Crivellato Developmental biology 372 (2), 157-165, 2012 | 402 | 2012 |
| Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy F Pastorino, C Brignole, D Marimpietri, M Cilli, C Gambini, D Ribatti, ... Cancer research 63 (21), 7400-7409, 2003 | 397 | 2003 |
| MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma AM Roccaro, A Sacco, B Thompson, X Leleu, AK Azab, F Azab, J Runnels, ... Blood, The Journal of the American Society of Hematology 113 (26), 6669-6680, 2009 | 391 | 2009 |
| Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and antiangiogenesis in vivo D Ribatti, B Nico, A Vacca, L Roncali, PH Burri, V Djonov The Anatomical Record: An Official Publication of the American Association …, 2001 | 391 | 2001 |
| Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. M Ziche, D Maglione, D Ribatti, L Morbidelli, CT Lago, M Battisti, I Paoletti, ... Laboratory investigation; a journal of technical methods and pathology 76 (4 …, 1997 | 390 | 1997 |
| Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells AM Roccaro, T Hideshima, N Raje, S Kumar, K Ishitsuka, H Yasui, ... Cancer research 66 (1), 184-191, 2006 | 380 | 2006 |
| The concept of immune surveillance against tumors: The first theories D Ribatti Oncotarget 8 (4), 7175, 2017 | 372 | 2017 |
| Antiangiogenesis is produced by nontoxic doses of vinblastine A Vacca, M Iurlaro, D Ribatti, M Minischetti, B Nico, R Ria, A Pellegrino, ... Blood, The Journal of the American Society of Hematology 94 (12), 4143-4155, 1999 | 363 | 1999 |
| The history of the angiogenic switch concept D Ribatti, B Nico, E Crivellato, AM Roccaro, A Vacca Leukemia 21 (1), 44-52, 2007 | 326 | 2007 |
| Angiogenesis in pre-malignant conditions M Raica, AM Cimpean, D Ribatti European journal of cancer 45 (11), 1924-1934, 2009 | 316 | 2009 |
| The gelatin sponge–chorioallantoic membrane assay D Ribatti, B Nico, A Vacca, M Presta Nature protocols 1 (1), 85-91, 2006 | 316 | 2006 |
